SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale of 1,975,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3.95 million, in a registered direct offering priced at-the-market under Nasdaq rules. The offering is … [Read more...] about SenesTech Announces $3.95 Million Direct Offering of Stock Priced At-the-Market Under Nasdaq Rules
senesTech
SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced private placement of 4,388,854 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 2,194,427 shares of common stock, at a purchase price of $2.2785 per share of common stock (or common stock equivalent in lieu thereof) and … [Read more...] about SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 12:00pm ET (9:00am PT). A webcast of the presentation will be posted under the investor relations section of SenesTech's website at senestech.investorroom.com, can be accessed … [Read more...] about SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
SenesTech, Inc. (Nasdaq: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the pricing of its public offering of 1,574,308 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one warrant to purchase one share of common stock. The units are being offered at a public offering price of $3.176 per unit priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. is acting as … [Read more...] about SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
New York State Approval is Major Step For SenesTech
SenesTech, a leader in technology for managing animal pest populations through fertility control, is celebrating the registration approval from New York state for the marketing and sale of ContraPest. As a result of the anticipated demand for the product to control rat infestations, the Flagstaff company is ramping up manufacturing capabilities. SenesTech’s existing manufacturing capacity, estimated at 300,000 liters per year, is expected to double under current expansion plans. SenesTech, … [Read more...] about New York State Approval is Major Step For SenesTech
SenesTech Hires Dr. Sandra Alcaraz to Promote Regulatory Approval
SenesTech, Inc., a developer of novel proprietary technologies for managing animal pest populations through fertility control, is hiring Dr. Sandra Alcaraz as vice president, regulatory affairs. The company also is providing further details on its international expansion strategy. Dr. Alcaraz is experienced in biological sciences, international regulatory affairs and the development and marketing of disruptive technologies and novel products. Dr. Alcaraz has a special expertise in launching … [Read more...] about SenesTech Hires Dr. Sandra Alcaraz to Promote Regulatory Approval
SenesTech Taps Bioceres to Seek Argentine Approval for ContraPest
A developer of proprietary technologies for managing animal pest populations through fertility control, today announced that jointly with Bioceres, a leading Argentine agricultural biotechnology company1 , it will seek Argentine regulatory approval for ContraPest®, SenesTech's patent protected technology for managing rodent pest populations through reducing fertility. Under the agreement, Bioceres, through its subsidiary INMET S.A., will immediately proceed on SenesTech's behalf to obtain … [Read more...] about SenesTech Taps Bioceres to Seek Argentine Approval for ContraPest
